Looking to drop those stubborn pounds? The weight loss world is buzzing about a game-changing medication that's helping ...

The increasing use of Ozempic for modest weight loss has sparked intense debate within medical communities, raising questions ...

Renowned plant-based physician Dr. Michael Greger has released a new book on the risks, benefits, and alternatives to Ozempic ...

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates of surgery dropped by one quarter.

Study of those who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just the ...

After insurance for New York City employees began covering GLP-1 weight-loss injectables, more than 1,000 city workers and ...

In a world increasingly focused on health and wellness, finding effective solutions for weight management can be challenging.

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

A recent commentary published in The Lancet journal highlights the critical importance of skeletal muscle mass in the context ...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according to a new analysis of U.S. health insurance claims.